AKEBIA THERAPEUTICS, INC. Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
AKEBIA THERAPEUTICS, INC. (AKBA) had Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax of $2.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2017-11-08
- 2017-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $2.00K.
- 2017-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $2.00K.
- 2016-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $12.00K.
- 2016-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $43.00K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax as first filed |
|---|---|---|
| 2017-09-30 | $2.00K 10-Q · filed 2017-11-08 | |
| 2017-03-31 | $2.00K 10-Q · filed 2017-05-09 | |
| 2016-09-30 | $12.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $43.00K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $22.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $1.00K 10-K · filed 2017-03-06 | |
| 2015-09-30 | $20.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $12.00K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $17.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $4.00K 10-K · filed 2016-03-14 | $3.86K 10-K · filed 2015-03-04 |
| 2014-09-30 | $3.30K 10-Q · filed 2014-11-10 | |
| 2013-12-31 | $2.47K 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |